New national report confirms scale and impact of gynaecological cancers in Australia

MEDIA RELEASE 
For Immediate Release  

Gynaecological cancers remain among the most complex, least understood, and under-recognised health challenges facing Australian women today. The latest Gynaecological Cancer in Australia 2025 Overview, to be released on 1 September to mark Gynaecological Cancer Awareness Month and Women's Health Week — reveals the confronting reality:

• 19 women will be diagnosed with a gynaecological cancer every day, with diagnoses projected to rise by 21% over the next 10 years.
• Over 55% of gynaecological cancers are rare or less common, meaning there are limited treatment options available.
• 6 women will die from one of these cancers daily, and
• More than 42,900 children are expected to lose their mothers over the next decade. 

These cancers, including uterine (and endometrial), ovarian, cervical, vulvar and vaginal, together contribute to a significant proportion of cancer-related deaths in women. Unlike other cancers and chronic diseases, gynaecological cancers often grow silently during the curable stage, so that when detected, the cancer is often advanced and incurable

ANZGOG CEO, Alison Evans, said the report underscores the urgent need for change.

“Gynaecological cancers have some of the poorest outcomes and the widest inequities of any major cancer group. Women are being diagnosed late, they are unable to access the best treatments for their cancer and are left feel isolated and unheard. This must change.” 

The new Gynaecological Cancer in Australia 2025 Overview draws on the latest national data to highlight the growing burden of these cancers, including the stark inequities faced by women in regional, rural and remote areas, those from lower socioeconomic backgrounds, and First Nations women, reinforcing the need for urgent action. 

Despite the sobering statistics, ANZGOG says there is hope. Advances in research, molecular profiling and clinical trials are beginning to transform care, but only if investment and awareness follow. 

“Research saves lives. This report is a call to action to ensure women are no longer left behind, and that every woman, regardless of where she lives or who she is, has access to the best possible diagnosis, treatment and support.” said ANZGOG CEO, Alison Evans.

The Gynaecological Cancer in Australia 2025 Overview will be publicly available from 1 September 2025 at anzgog.org.au.

ENDS 

For media interviews or to access an embargoed copy of the report, please contact: Monique Cerreto: T: 0416 282 464, E: [email protected] 

About Australia New Zealand Gynaecological Oncology Group (ANZGOG):  

ANZGOG is the peak national gynaecological cancer research organisation in Australia and New Zealand. We foster and lead innovative, world-class multidisciplinary research to improve outcomes and quality of life for everyone with a lived experience of gynaecological cancer.  

Our vision is clear: Advancing research, saving lives. 

For over 26 years, ANZGOG has enabled over 60 clinical trials across all types of gynaecological cancer, involving more than 4,500 patients. These trials are delivered through over 80 hospital sites, supported by both local and global research collaborations.  

Our growing network includes over 1,500 members across clinical, allied health, and pure research disciplines—alongside community representatives who ensure the voices of women with lived experience are at the centre of everything we do.